Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy

Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy

BackgroundExtended-release buprenorphine (BUP-XR) is a once-monthly subcutaneous injection for the treatment of opioid use disorder. Injection-site pain is a common adverse event reported with BUP-XR administration. Notwithstanding the advantages of BUP-XR, subjective pain and anxiety associated wit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pouya Azar, Jane J. Kim, Ella Rohani, Dayyon Newman-Azar, Matin Narimani, Jessica Machado, Victor W. Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Psychiatry
Subjects:	opioid use disorder lidocaine extended-release buprenorphine injection site pain case series
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1500799/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report
by: Pouya Azar, et al.
Published: (2025-05-01)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01)

Ketamine treatment for buprenorphine-precipitated opioid withdrawal: a case report
by: Ezioma Gbujie, et al.
Published: (2025-06-01)

Patients' perspectives on buprenorphine subcutaneous implant: a case series
by: Claudio Pierlorenzi, et al.
Published: (2024-04-01)

Characterizing withdrawal from long-acting injectable buprenorphine: An observational case series
by: Victoria Hayes, et al.
Published: (2025-06-01)

Patient Satisfaction and Resource Utilization Following Introduction of Long-Acting Injectable Buprenorphine (LAIB) in Scottish Prisons
by: Sayers C, et al.
Published: (2025-04-01)

Outpatient-based buprenorphine-assisted opioid withdrawal management: A preliminary prospective observational study
by: Avinash Jhajharia, et al.
Published: (2025-04-01)

Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain
by: Mateusz Szczupak, et al.
Published: (2025-04-01)

Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl
by: Bradley D. Stein, et al.
Published: (2025-04-01)

Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review
by: Kathleen K. Adams, et al.
Published: (2025-02-01)

Buprenorphine/naloxone initiation in the emergency department: A series of vignettes
by: Margarita Popova, et al.
Published: (2024-12-01)

Emergency department‐initiated buprenorphine protocols: A national evaluation
by: Clara Z. Guo, et al.
Published: (2021-12-01)

Patient acceptance of emergency department-initiated buprenorphine and reasons for declining
by: Lindsey K. Jennings, et al.
Published: (2025-03-01)

Breaking barriers: Assessing the feasibility and acceptability of telemedicine-assisted buprenorphine induction for opioid use disorder in India
by: Abhishek Ghosh, et al.
Published: (2024-10-01)

Advancing emergency department–initiated buprenorphine
by: Kristen Huntley, et al.
Published: (2021-06-01)

Age and racial and ethnic disparities in filled buprenorphine prescriptions post‐emergency department visit in Nevada
by: Olufemi Ajumobi, et al.
Published: (2024-10-01)

Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: A randomized, double blind, placebo-controlled study
by: Jamshid Ahmadi, et al.
Published: (2020-01-01)

Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
by: Winter Roth, PharmD, BCPP, et al.
Published: (2025-04-01)

Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis
by: Aline Lott, et al.
Published: (2025-04-01)

Impact of Lidocaine Concentration on Analgesic Efficacy and Adverse Events in Dermatologic Infiltrative Anesthesia
by: Van Thanh Le Thai, et al.
Published: (2025-07-01)

Is buprenorphine use in pregnancy linked to decreased fetal breathing movement
by: Caroline M. Bulger, et al.
Published: (2025-05-01)

Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis
by: Kevin Y. Xu, et al.
Published: (2025-01-01)

Treating Opioid Use Disorder on the Inpatient Psychiatric Unit: A Novel Buprenorphine Consultation Service
by: Sean T. Lynch, et al.
Published: (2025-05-01)

First, Do No Harm: Buprenorphine Use for Pain Associated with Chronic Diseases
by: Amanda Springer, et al.
Published: (2024-11-01)

Anesthetic management and post-operative anesthesia for patients who underwent extended liver resection: the role of intravenous lidocaine
by: R. A. Zatsarynnyi, et al.
Published: (2022-07-01)

Methadone and Buprenorphine as Medication for Addiction Treatment Diversely Affect Inflammation and Craving Depending on Their Doses
by: Christonikos Leventelis, et al.
Published: (2025-03-01)

Comparing quality of life methadone and buprenorphine for opioid substitution treatment in Iran
by: Ahmad Nemati, et al.
Published: (2025-08-01)

Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder
by: Laura B. Monico, et al.
Published: (2025-02-01)

Buprenorphine's Effect on the Human Immune System and Inflammation
by: Samuel D. Shin, et al.
Published: (2025-03-01)

Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study
by: Melissa Davoust, et al.
Published: (2025-03-01)

Assessing buprenorphine treatment utilization and SAMHSA DATA waiver provider distribution in 2021: a real-world analysis in California
by: Yun Wang, et al.
Published: (2025-08-01)

Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders
by: Rebecca Fish, et al.
Published: (2025-06-01)

Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder
by: Marlene C. Lira, et al.
Published: (2025-02-01)

Effect of lidocaine ice button topical anesthesia on pain during maxillary buccal infiltration in 6–10-year children – A randomized control trial
by: Devendra I. Nagpal, et al.
Published: (2025-04-01)

EVALUATION OF PAIN SCALE ON CIRCUMCISION PATIENTS UNDER LIDOCAINE HYDROCHLORIDE LOCAL ANESTHESIA
by: Baraz Aulia Achmad, et al.
Published: (2025-05-01)

Expanding buprenorphine prescribing in primary care: a qualitative study of the experiences of primary care providers and nurse care managers participating in the New York City buprenorphine nurse care manager initiative
by: Elodie C. Warren, et al.
Published: (2025-08-01)

Influence of intravenous lidocaine infusion on haemodynamic response to tracheal intubation and metabolic-hormonal responses during laparoscopic procedures in children: a randomised controlled trial
by: Maciej Kaszyński, et al.
Published: (2025-01-01)

An Indigenous-led buprenorphine-naloxone treatment program to address opioid use in remote Northern Canada
by: Aleksandra M. Zuk, et al.
Published: (2024-12-01)

Expanding Horizons of Buprenorphine: A Comprehensive Narrative Review of Its Pharmacological Properties and Clinical Applications in Chronic Pain
by: Diego Fornasari, et al.
Published: (2025-06-01)

Security and efficacy of intravenous injection of lidocaine in major hepatic resection
by: R. A. Zatsarynnyi, et al.
Published: (2022-12-01)